Clinical and Translational Nutrition

Panel Discussion - New Insights Into the Far-Reaching Effects of Obesity Medicines

Moderator(s)

• LW

  Leah Whigham, PhD, FTOS

  Professor
  University of Texas at Austin, United States

  Disclosure information not submitted.

Speaker(s)

• GF

  Gary D. Foster, PhD

  University of Pennsylvania, United States

  Disclosure information not submitted.
• 

  Ted Kyle, RPh, MBA (he/him/his)

  Founder
  ConscienHealth
  Pittsburgh, Pennsylvania, United States

  Disclosure(s): Boehringer Ingelheim: Advisory Committee/Board Member (Ongoing)
  Emerald Lake Safety: Independent Contractor (including contracted research) (Ongoing)
  Novo Nordisk: Advisory Committee/Board Member (Ongoing); Speaker/Speaker's Bureau (Ongoing)
  Nutrisystem: Consultant (Ongoing)
  Roman Health Ventures: Advisory Committee/Board Member (Ongoing)
• 

  Randy Seeley, PhD (he/him/his)

  Henry King Ransom Endowed Professor of Surgery, Internal Medicine, and Nutritional Sciences
  University of Michigan
  Ann Arbor, Michigan, United States

  Disclosure(s): Amgen: Advisory Committee/Board Member (Ongoing); Grant/Research Support (Ongoing)
  AstraZeneca: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Congruence: Grant/Research Support (Ongoing)
  Coro Bio: Advisory Committee/Board Member (Ongoing); Ownership Interest (Ongoing)
  Crinetics: Advisory Committee/Board Member (Ongoing)
  Eli Lilly: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Fractyl: Advisory Committee/Board Member (Ongoing); Grant/Research Support (Ongoing)
  Glyscend: Grant/Research Support (Ongoing)
  Metsera: Consultant (Ongoing)
  Novo Nordisk: Consultant (Terminated, January 1, 2024); Grant/Research Support (Terminated, January 1, 2024)
  Nuanced Health: Advisory Committee/Board Member (Ongoing); Ownership Interest (Ongoing)
  Rewind: Ownership Interest (Ongoing)